A heat advisory in effect for 6 regions in the area
See the complete list
Published:
Carmen Calfa M.D., a breast medical oncologist at Sylvester Comprehensive Cancer Center and Chair of the TAPUR Steering Group of the American Society of Clinical Oncology (ASCO), explains how the TAPUR trial is offering molecularly targeted therapies to eligible late-stage cancer patients using FDA-approved medications. Susan Spak is one of those patients.